药物受理最新动态：Pfizer Inc.PF-07868489补充申请获受理

Core Viewpoint - Pfizer Inc. has had its application for PF-07868489 accepted by the National Medical Products Administration, indicating progress in the approval process for this therapeutic biological product [1] Group 1: Application Details - The application for PF-07868489 was accepted on January 15, 2026, with the acceptance number JXSB2600007 [1] - PF-07868489 is categorized as a therapeutic biological product and is classified as a supplementary application under registration category 1 [1] Group 2: Company Information - Pfizer Inc. was established on October 7, 1989, and is a foreign-owned limited liability company engaged in the manufacturing of chemical pharmaceutical preparations [1] - The company has a registered capital of 80.4 million USD and a paid-in capital of 80.4 million USD, with 935 employees [1] - The sole shareholder is American Wyeth Corporation, holding 100% of the shares with a contribution of 80.4 million USD, registered on November 30, 2017 [1]